Sonify Biosciences, LLC

Sonify Biosciences specializes in developing melanoma treatment based on non-chemical, non-ablative ultrasound technology.

Sonify Biosciences specializes in developing melanoma treatment based on non-chemical, non-ablative ultrasound technology. It focuses primarily on exploring low-intensity focused ultrasound as a treatment for melanoma and other cancers. The company was founded in 2012 and is headquartered in Baltimore, Maryland.